Skip to main content
Top
Published in: Sleep and Breathing 3/2014

01-09-2014 | Obituary

Obituary Makoto Kikuchi

Author: Niki Netzer

Published in: Sleep and Breathing | Issue 3/2014

Login to get access

Excerpt

Our beloved friend and colleague Makoto Kikuchi has died after a short battle with cancer on March 27, 2014. He was in close contact with me over the last months as he managed the handover of his chairmanship of the Japanese Academy of Dental Sleep Medicine and his editorial board position with this journal to his colleague and scholar Morio Tonogi. Makoto and I discussed an operation of his tumor, but Makoto had decided after talks with his close ones and local physicians to disregard further invasive therapies—a personal decision we have to accept with full respect. Makoto had such a fulfilled life that he could “close out”, to use that term from baseball, Japans most popular sport, without remorse. …
Metadata
Title
Obituary Makoto Kikuchi
Author
Niki Netzer
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 3/2014
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-014-0995-8

Other articles of this Issue 3/2014

Sleep and Breathing 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine